Osteotech's Plexur P(TM) Receives FDA Clearance as Bone Void Filler and Bone Graft Extende...(e detailed from time to time in the Comp...)

Date:4/25/2008

e detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission. All information in this press release is as of April 25, 2008 and the Company does not intend to update this information.

'/>"/>

SOURCE Osteotech, Inc. Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related biology technology :

1. Osteotech Receives FDA Clearance for Plexur M(TM) Biocomposite
2. Diamics Receives European CE Mark Approval for Its Pap-Map(TM) System for Cervical Cancer Screening
3. Angiotech elects to suspend Vascular Wrap(TM) pivotal clinical trials
4. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
5. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
6. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
7. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
8. IsoTis Receives FDA Clearance for Accell Family of Products
9. Actavis Receives Approval of Fentanyl Transdermal System in the U.S.
10. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
11. IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma